Verjee Rehan 4
4 · Tyra Biosciences, Inc. · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Tyra Biosciences (TYRA) Director Rehan Receives Option Award
What Happened
Director Rehan (Verjee Rehan) received a grant of a derivative award—an option covering 13,160 shares of Tyra Biosciences common stock—reported on a Form 4 with a transaction date of 2026-05-28. The reported acquisition price is $0.00 (the award itself), so no cash changed hands at grant and no immediate sale or purchase in the market occurred.
Key Details
- Transaction date: 2026-05-28; Form 4 filed: 2026-06-01 (filed within required reporting window).
- Transaction type/code: A (award/grant) — derivative option covering 13,160 shares; acquisition value shown as $0.00.
- Vesting: The option vests 1/12th monthly beginning May 28, 2026. If the next annual meeting occurs before the first anniversary, any remaining unvested portion will vest at that meeting, subject to continued service (per footnote).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Exercise/strike price: Not stated in the provided summary—this grant is an unexercised option award, not an exercised or sold position.
Context
This is a routine director compensation grant under Tyra’s Non-Employee Director Compensation Program. As an unvested option award, it does not represent immediately tradable shares until vested and, if exercised, paid for. Such grants are common for board members and are administrative/compensation events rather than open-market insider purchases or sales.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-05-28+13,160→ 13,160 totalExercise: $32.68Exp: 2036-05-27→ Common Stock (13,160 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 28, 2026, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date.